Bio-Techne Corporation Forecast, price target & analysts
Bio-Techne Corporation Target price 2025 - Analyst rating & recommendation
Bio-Techne Corporation Classifications & Recommendation:
Bio-Techne Corporation Price Target
| Target Price | $66.63 |
| Price | $52.83 |
| Potential |
26.11%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Bio-Techne Corporation 2026 .
The average Bio-Techne Corporation target price is $66.63.
This is
26.11%
register free of charge
$87.15
64.96%
register free of charge
$55.55
5.15%
register free of charge
|
|
| A rating was issued by 24 analysts: 17 Analysts recommend Bio-Techne Corporation to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Bio-Techne Corporation stock has an average upside potential 2026 of
26.11%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.16 | 1.24 |
| 1.97% | 7.07% | |
| EBITDA Margin | 24.30% | 34.77% |
| 15.48% | 43.08% | |
| Net Margin | 14.50% | 24.64% |
| 42.21% | 69.92% |
20 Analysts have issued a sales forecast Bio-Techne Corporation 2025 . The average Bio-Techne Corporation sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Bio-Techne Corporation EBITDA forecast 2025. The average Bio-Techne Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Bio-Techne Corporation Analysts have issued a net profit forecast 2025. The average Bio-Techne Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.05 | 1.95 |
| 40.34% | 85.71% | |
| P/E | 25.71 | |
| EV/Sales | 6.49 |
20 Analysts have issued a Bio-Techne Corporation forecast for earnings per share. The average Bio-Techne Corporation EPS is
This results in the following potential growth metrics and future valuations:
Bio-Techne Corporation...
Current Bio-Techne Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Jul 11 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Jun 05 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 30 2025 |
| UBS |
Locked
➜
Locked
|
Locked | May 09 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Jul 11 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 09 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Jun 05 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 30 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
